Resmed (RSMDF) Gross Margin (2009 - 2026)

Resmed has reported Gross Margin for 18 years, with the latest figure at 62.25% in Q1 2026.

• For the quarter ending Q1 2026, Gross Margin rose 291.0% year-over-year to 62.25%; the trailing twelve-month figure through Mar 2026 stood at 61.59% (up 283.0% YoY), and the FY2025 full-year result was 59.36%, up 269.0% from the prior year.
• Gross Margin for Q1 2026 stood at 62.25%, up from 61.76% in the prior quarter.
• The five-year high for Gross Margin was 62.25% in Q1 2026, with the low at 54.44% in Q3 2023.
• Historically, Gross Margin has averaged 58.03% across 5 years, with a median of 57.88% in 2024.
• Annual changes were most pronounced in 2023 — Gross Margin slumped 247 bps — and 2024, when it jumped 414 bps.
• Resmed's Gross Margin stood at 56.08% in 2022, then decreased by 1 bps to 55.64% in 2023, then increased by 5 bps to 58.6% in 2024, then climbed by 5 bps to 61.76% in 2025, then rose by 1 bps to 62.25% in 2026.
• The last three Gross Margin figures came in at 62.25% (Q1 2026), 61.76% (Q4 2025), and 61.46% (Q3 2025), per Business Quant data.